[HTML][HTML] Incorporating neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in place of neutrophil count and platelet count improves prognostic accuracy of …

P Chrom, R Stec, L Bodnar… - Cancer Research and …, 2018 - ncbi.nlm.nih.gov
Purpose The study investigated whether a replacement of neutrophil count and platelet count
by neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) within the …

Effects of an outpatient intervention comprising nurse‐led non‐invasive assessments, telemedicine support and remote cardiologists' decisions in patients with heart …

…, P Siwołowski, P Gutknecht, P Chrom… - European Journal of …, 2022 - Wiley Online Library
Aim Prevention of heart failure (HF) hospitalisations and deaths constitutes a major therapeutic
aim in patients with HF. The role of telemedicine in this context remains equivocal. We …

Second-line treatment of advanced gastric cancer: current options and future perspectives

P Chrom, R Stec, C Szczylik - Anticancer Research, 2015 - ar.iiarjournals.org
Due to its high incidence and poor prognosis, gastric cancer is an important health problem
worldwide. The only possible curative treatment is to remove the primary tumor at an early …

[HTML][HTML] Fuhrman grade and neutrophil-to-lymphocyte ratio influence on survival in patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase …

P Chrom, R Stec, A Semeniuk-Wojtas, L Bodnar… - Clinical genitourinary …, 2016 - Elsevier
Background The present study investigated the various features that might influence the
overall survival (OS) of patients with metastatic renal cell carcinoma (RCC) treated with first-line …

External validation of the systemic immune-inflammation index as a prognostic factor in metastatic renal cell carcinoma and its implementation within the international …

P Chrom, J Zolnierek, L Bodnar, R Stec… - International journal of …, 2019 - Springer
Background We conducted a study to validate the influence of the systemic immune-inflammation
index (SII) on overall survival (OS) in patients with metastatic renal cell carcinoma (…

Prognostic significance of pancreatic metastases from renal cell carcinoma in patients treated with tyrosine kinase inhibitors

P Chrom, R Stec, L Bodnar, C Szczylik - Anticancer research, 2018 - ar.iiarjournals.org
Aim: The study aimed to define the true impact of pancreatic metastases (PM) from renal cell
carcinoma on overall survival (OS) in patients treated with first-line tyrosine kinase inhibitors…

Real-world experience of cabozantinib as second-or subsequent line treatment in patients with metastatic renal cell carcinoma: data from the polish managed access …

…, J Żołnierek, M Wieczorek-Rutkowska, P Chrom… - Clinical Genitourinary …, 2019 - Elsevier
Background Cabozantinib is an approved treatment for metastatic renal cell carcinoma (mRCC).
This report presents an analysis of the safety profile and efficacy of cabozantinib in an …

Rationale and design of the AMULET study: A new Model of telemedical care in patients with heart failure

…, A Galas, A Walczak, P Murawski, P Chrom… - ESC heart …, 2021 - Wiley Online Library
Paweł Krzesiński did the conception and design of the … for important intellectual content;
Paweł Chrom did the conception and … for important intellectual content; Paweł Siwołowski did the …

NBE-002: a novel anthracycline-based antibody-drug conjugate (ADC) targeting ROR1 for the treatment of advanced solid tumors—A phase 1/2 clinical trial.

…, L Waldmeier, R Gebleux, I Hellmann, P Chrom… - 2021 - ascopubs.org
TPS1108 Background: The receptor tyrosine kinase-like orphan receptor 1 (ROR1) is highly
expressed during embryonic development, but is minimally present or absent on post-…

Nurse‐led ambulatory care supported by non‐invasive haemodynamic assessment after acute heart failure decompensation

…, P Siwołowski, P Gutknecht, P Chrom… - ESC heart …, 2021 - Wiley Online Library
Heart failure (HF) is characterized by frequent decompensation and an unpredictable trajectory.
To prevent early hospital readmission, coordinated discharge planning and individual …